Tracked vehiclesAnduril Enterprise 0.87% fill $173.4M / $20BCBP AST 46.50% fill $929.9M / $2.0BPalantir Maven 81.60% fill $637.6M / $781.3MShield AI USCG $61.4M drawn 12 ordersCounter-drone $2.1B drawn 25 C-UAS vehicles and awardsUSAspending compile · Oct 9 2026
AwardTape

AwardTape · Defense awards · Medical · Drugs and biologicals · HT940823A0004

HT940823A0004: $0 blanket purchase agreement to Wells Pharma of Houston LLC

Wells Pharma of Houston LLC holds a blanket purchase agreement from Defense Health Agency with $0 obligated since Oct 2023, against a ceiling of $250K. Latest action Jan 8, 2024.

Prefilled syringes, naval hospital pensacola, fl

PIIDHT940823A0004
Typeblanket purchase agreement
CompanyWells Pharma of Houston LLC
AgencyDefense Health Agency
Contracting officeDEFENSE HEALTH AGENCY
CategoryMedical · Drugs and biologicals
PSC6505 DRUGS AND BIOLOGICALS
NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING
Obligated since Oct 2023$0
Total obligated (lifetime)$0
Ceiling (base and all options)$250K
Base dateSep 1, 2023
Latest actionJan 8, 2024
End daten/a
Actions since Oct 20231
PricingSet per order
CompetitionNot reported
SourceUSAspending.gov record
Reporting lagDoD 90 days
About this record

Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.

Terminal: alerts on new orders and modifications to this contract, and CSV export.

7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.

Start free trial